By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Shares of Caliper Life Sciences and Genomic Health rose 30 percent each during November, as the GenomeWeb Daily News Index outperformed the broader market.

Overall, 15 of the 33 stocks in the GWDN Index rose for the month. The Index finished November up 2 percent, while the Dow Jones Industrial Average was down 1 percent, the Nasdaq was virtually flat, and the Nasdaq Biotech Index slipped 2 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.